Stephen Ubl's guest appearances

Stephen Ubl

POLITICO's Pulse Check

DeviceTalks

A Second Opinion with Senator Bill Frist, M.D.

Tom Frieden

Aneesh Chopra

Jeff Goldsmith

Andy Slavitt

Scott Gottlieb

Dean Kamen

Lamar Alexander

Mandy Cohen

Ashish Jha

Johns Hopkins

Douglas Holtz-Eakin

Rod Hochman

Jerome Adams

Peter Pronovost

Leana Wen

OwlTail

Stephen Ubl is the president and CEO of the Pharmaceutical Research and Manufacturers of America, known as PhRMA, which represents America's leading biopharmaceutical research companies.  The U.S. biopharmaceutical sector directly employs more than 800,000 Americans and invests more than $100 billion in research and development annually -- more than any other industry in America.  Steve leads the advocacy for this industry in Washington, DC and across the country.  A policy expert with a record of enacting meaningful healthcare reform, Steve joins me today to do a deep dive on the drug industry – examining costs, the supply chain, and the industry’s unprecedented response to Covid-19.

Stephen Ubl is the president and CEO of the Pharmaceutical Research and Manufacturers of America, known as PhRMA, which represents America's leading biopharmaceutical research companies.  The U.S. biopharmaceutical sector directly employs more than 800,000 Americans and invests more than $100 billion in research and development annually -- more than any other industry in America.  Steve leads the advocacy for this industry in Washington, DC and across the country.  A policy expert with a record of enacting meaningful healthcare reform, Steve joins me today to do a deep dive on the drug industry – examining costs, the supply chain, and the industry’s unprecedented response to Covid-19.

121 - Stephen Ubl, President & CEO of PhRMA, on drug pricing, supply chains, and the industry’s miraculous Covid-19 response

President Donald Trump says the drug industry is "getting away with murder" — but Stephen Ubl, the nation's top pharma lobbyist, says his industry's life-saving work has been overshadowed by a few bad actors. Ubl joined POLITICO's Dan Diamond to share his thoughts on drug prices, his recent meeting with Trump, PhRMA's top priorities, and why Martin Shkreli and other controversial figures don't tell the whole story about the industry. (Starts at the 1:45 mark.) Then after the break, POLITICO's pharma reporter Sarah Karlin-Smith discusses her reporting on drug price reform. (Starts at 28:00.) We’d appreciate your help: Please share PULSE CHECK and rate us on your favorite podcast app! Have questions, suggestions or feedback? Email ddiamond@politico.com.

President Donald Trump says the drug industry is "getting away with murder" — but Stephen Ubl, the nation's top pharma lobbyist, says his industry's life-saving work has been overshadowed by a few bad actors. Ubl joined POLITICO's Dan Diamond to share his thoughts on drug prices, his recent meeting with Trump, PhRMA's top priorities, and why Martin Shkreli and other controversial figures don't tell the whole story about the industry. (Starts at the 1:45 mark.) Then after the break, POLITICO's pharma reporter Sarah Karlin-Smith discusses her reporting on drug price reform. (Starts at 28:00.) We’d appreciate your help: Please share PULSE CHECK and rate us on your favorite podcast app! Have questions, suggestions or feedback? Email ddiamond@politico.com.

PhRMA's Stephen Ubl on drug prices, lab coats (not hoodies), and talking with Trump

Before Stephen Ubl departed for a job as the chief lobbyist for the pharmaceutical industry, medtech's main man in Washington D.C. sat down with us to reflect on his time as CEO of AdvaMed. In this episode of DeviceTalks, we go deep into Ubl's background, the fights over the medical device tax, forging a new partnership with the FDA and more.

Exit interview: Stephen Ubl moves on from AdvaMed